University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 14 of 26

COMPLETED NA

Effect of Guided Imagery for Radiotherapy-Related Distress in Patients With Head and Neck Cancer

NCT03662698

COMPLETED NA

Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS

NCT03717935

COMPLETED Phase 1

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

NCT03620773

COMPLETED Phase 1

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

NCT03618420

COMPLETED Phase 2

Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer

NCT03475004

COMPLETED

Observational Hemodynamic Monitoring During LVAD Implantation Among Individuals With Advanced Heart Failure

NCT03464981

COMPLETED Phase 2

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

NCT03582137

COMPLETED NA

Breathing Training to Improve Human Performance at High Altitude

NCT03530163

COMPLETED NA

Facing Your Fears in Schools: Implementing a CBT Program for Students With ASD or Other Special Learning Needs

NCT03685474

COMPLETED NA

Pilot Evaluation of Hospice Decision Support Tools

NCT03794700

COMPLETED NA

Incentives for Adherence in Adolescent Asthma

NCT03515499

COMPLETED NA

Assisting in Decisions in Emergency Departments: (ED-AID) Study

NCT03478501

COMPLETED

Pubertal Blockade and Hormone Therapy in Transgender Youth

NCT03557268

COMPLETED

Cancer Survivors and Their Romantic Partners' Preferences for a Couples-based Physical Activity

NCT04471363

COMPLETED Phase 2

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty

NCT03409588

COMPLETED

Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder

NCT03572426

COMPLETED NA

Reducing Distress in Phase 1 Trial Caregivers: The P1-CaLL Study

NCT03557515

COMPLETED NA

Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease

NCT03342742

COMPLETED NA

Pilot Study of Time Restricted Feeding as a Weight Loss Intervention

NCT03571048

TERMINATED

Evaluation of Ocular Lens Proteins in Cataract From Individuals With Down Syndrome

NCT03778528

COMPLETED NA

A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators

NCT03374891

COMPLETED

Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease

NCT03548818

COMPLETED

Novel Strategies for Personalized Clinical Decisions in Knee Arthroplasty

NCT05900453

COMPLETED NA

Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis

NCT03305653

COMPLETED NA

Computerized Cognitive Behavioral Treatment for Insomnia: Improving Rural Veteran Access to Evidence-Based Treatment to Reduce Suicide Risk (R-Vets Sleep)

NCT03365024

COMPLETED NA

Comparison of Braces for Treatment of Sever's Disease

NCT03494647

COMPLETED NA

Longitudinal, Multi-Dimensional Assessment of Recovery and Added Benefit of a Behavioral Health Intervention for Children With Abusive Head Trauma

NCT03447899

COMPLETED NA

Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk

NCT03366870

COMPLETED NA

A Novel Lung Function Imaging Modality As a Preoperative Evaluation Tool (LIME)

NCT03426306

COMPLETED

EMT in Peritoneal Dialysis Patients

NCT03458819

COMPLETED Phase 1

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

NCT03335163

COMPLETED

Return to Sport After Posterior Spinal Fusion

NCT03513120

TERMINATED NA

Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance

NCT03112902

COMPLETED NA

Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain

NCT03363243

COMPLETED

Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases

NCT03389399

COMPLETED NA

Feasibility and Preliminary Efficacy of a Reverse Diet as a Novel Weight Loss Maintenance Strategy for Weight-Reduced Adults With Overweight/Obesity

NCT03560635

COMPLETED NA

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

NCT03227458

COMPLETED NA

Effect of Warmed Irrigation in Hip Arthroscopy Undergoing Hip Arthroscopy

NCT03453866

COMPLETED NA

Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function

NCT03112226

COMPLETED NA

Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex

NCT03419195

COMPLETED NA

Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth

NCT03372915

COMPLETED NA

Psychosocial Intervention in Latino Patients with Advanced Cancer

NCT03763032

COMPLETED NA

Movement Pattern Biofeedback Training After Total Knee Arthroplasty

NCT03325062

COMPLETED NA

A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

NCT03087903

TERMINATED Early Phase 1

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

NCT03380936

COMPLETED NA

Resuscitation of Infants With Congenital Diaphragmatic Hernia With an Intact Umbilical Cord

NCT03242044

COMPLETED NA

Electronic Health Record-leveraged, Patient-centered, Intensification of Chronic Care for HF

NCT03334188

TERMINATED NA

The Influence of Gonadal Hormone Suppression on Adipocyte Lineage and the Microbiome

NCT03396978

COMPLETED NA

Integrating Palliative Care Social Workers Into Sub-Acute Settings: A Feasibility Trial

NCT03546920

COMPLETED Phase 4

Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)

NCT03126370

← Previous Page 14 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.